The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiling, N.
Right arrow Articles by Ehlers, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiling, N.
Right arrow Articles by Ehlers, S.
The Journal of Immunology, 2002, 169: 3480-3484.
Copyright © 2002 by The American Association of Immunologists

Cutting Edge

Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1

Norbert Reiling2,*, Christoph Hölscher2,*, Alexandra Fehrenbach*, Svenja Kröger*, Carsten J. Kirschning{dagger}, Sanna Goyert{ddagger} and Stefan Ehlers3,*

* Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany; {dagger} Institute of Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, Munich, Germany; and {ddagger} Division of Molecular Medicine, Cornell University Medical College, Manhasset, NY 11030


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Innate resistance against Mycobacterium tuberculosis is thought to depend critically on engagement of pattern recognition receptors on macrophages. However, the relative contribution of these receptors for containing M. tuberculosis infection has remained unexplored in vivo. To address this issue, we infected mice defective in CD14, TLR2, or TLR4 with M. tuberculosis by aerosol. Following infection with 100 mycobacteria, either mutant strain was as resistant as congenic control mice. Granuloma formation, macrophage activation, and secretion of proinflammatory cytokines in response to low-dose aerosol infection were identical in mutant and control mice. However, high-dose aerosol challenge with 2000 CFU M. tuberculosis revealed TLR2-, but not TLR4-defective mice to be more susceptible than control mice. In conclusion, while TLR2 signaling contributes to innate resistance against M. tuberculosis in borderline situations, its function, and that of CD14 and TLR4, in initiating protective responses against naturally low-dose airborne infection is redundant.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Human tuberculosis caused by Mycobacterium tuberculosis is the most prevalent and deadly bacterial infectious disease world-wide (1). Incomplete understanding of the molecular nature of protective immune responses has hampered the development of more effective vaccines and therapies.

Animal models of low-dose aerosol infection with M. tuberculosis are believed to reflect the typical infection that occurs when humans inhale only a few virulent bacteria aerosolised in the course of an infected individual’s coughing (2, 3). Aerosol infection in mice has been instrumental in defining the prominent features of the cell-mediated immune response now known to be critical in host defense. In particular, CD4+ T cells play an important role in protective granuloma formation by secreting type 1 cytokines (4). Especially IFN-{gamma} and TNF (5) stimulate the antimicrobial activity of infected macrophages (6). Although TNF can activate macrophages in an autocrine loop, the release of IFN-{gamma} by NK and TH1 cells is triggered by IL-12, which is produced by APCs upon infection with mycobacteria (7).

Microbes express pathogen-associated molecular patterns capable of activating APCs following engagement of pattern recognition receptors (PRRs4; Refs. 8 and 9). Specifically, CD14 was reported to be engaged by lipoarabinomannan from M. tuberculosis, although subsequent studies questioned this finding (10, 11). In addition, analysis of transfected chinese hamster ovary fibroblasts suggested that live M. tuberculosis may use both Toll-like receptor (TLR)2 and TLR4 proteins for intracellular signaling (11). On a functional level, the interaction of mycobacterial components with TLRs may be a critical early step of macrophage activation in the course of infection. Thus, stimulation of TLR2 with the M. tuberculosis-derived 19-kDa lipoprotein induced mycobacteriostasis in both human and murine macrophages (12). Because TLR signaling is believed to be essential for the initial production of IL-12p40 and TNF by APCs after infection with M. tuberculosis, it is likely critical also for the induction of a protective cell-mediated immune response (13). In the absence of endogenous IL-12p40 or TNF, mice are severely compromised in terms of type 1 cytokine production, granuloma formation, and protection during mycobacterial infection (14, 15). Therefore, current thinking predicts that deficiencies in PRRs, such as TLR2 or TLR4, will be accompanied by greatly diminished innate immune responses resulting in early exacerbation of M. tuberculosis infection (16, 17, 18).

However, the role of TLR-mediated pathogen recognition for initiating the immune response against M. tuberculosis has thus far remained unexplored in vivo. To address this issue, we analyzed the course of aerosol M. tuberculosis infection in mice deficient in CD14, TLR2, or TLR4.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Mice and macrophages

TLR2- (TLR2-/-; 19) and CD14-deficient (CD14-/-) mice (20) were at least sixth generation backcrosses onto a C57BL/6 or BALB/c background, respectively. TLR4-defective C3H/HeJ (21) mice and the following congenic control mice were purchased from Charles River Breeding Laboratories (Sulzfeld, Germany): C57BL/6 (TLR2+/+), BALB/c (CD14+/+), and C3HHeN (TLR4-competent). Bone marrow-derived macrophages were generated as previously described (22).

Bacteria and infection

M. tuberculosis (H37Rv) was grown and prepared for all experiments as described (14). For in vitro experiments, 0.5 x 106 macrophages were infected with 0.5–50 x 106 CFU M. tuberculosis. As a control stimulus, LPS was used at 10 ng/ml (22).

Pulmonary infection of experimental animals with M. tuberculosis with a natural dose of 100 CFU/lung or a high dose of 2000 CFU M. tuberculosis per lung was performed as described (14). Inoculum size was confirmed 24 h postinfection by determining the bacterial load in the lungs of infected mice.

Colony enumeration assay

At different time points after infection with M. tuberculosis, lungs of sacrificed animals were removed aseptically and weighed, and one lobe per mouse was homogenized in PBS containing a proteinase inhibitor mixture (Roche Diagnostics, Mannheim, Germany). For colony enumeration, 10-fold serial dilutions of organ homogenates were plated in duplicates and processed as described (14).

Immunohistological analysis

One lung lobe per mouse was fixed in 4% formalin-PBS, set in paraffin blocks, and sectioned (2–3 µm). For immunohistology, tissue sections were prepared and stained with a polyclonal rabbit anti-mouse inducible NO synthase (iNOS) antiserum (Biomol, Hamburg, Germany) as previously described (23).

Quantification of IL-12p40, TNF, and IFN-{gamma} by ELISA

Supernatants were collected at 24 and 96 h postinfection, and mouse TNF- and IL-12p40-concentrations in the supernatants were measured by ELISA according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN and BD Bioscience, Heidelberg, Germany, respectively). Cytokine levels (TNF, IL-12p40, IFN-{gamma}) in lung homogenates and serum from infected mice were analyzed in 3-fold serial dilutions by a sandwich ELISA (OptEia; BD Bioscience).

Statistical analysis

Data are expressed as the means of individual determinations and SD. Statistical analysis was performed using the Student t test or the log rank survival test.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
Course of aerosol infection with 100 CFU M. tuberculosis in mice deficient in CD14, TLR2, or TLR4

During the course of aerosol infection with 100 CFU M. tuberculosis, the bacterial load in the lungs of BALB/c mice was almost identical with that found in CD14-/- mice (Fig. 1Goa). Likewise, TLR4-defective C3H/HeJ (Fig. 1Gob) and TLR2-/- mice (Fig. 1Goc) were as resistant to aerosol infection with M. tuberculosis as congenic control mice, respectively, refuting the hypothesis that TLR2 or TLR4 by themselves are of pivotal significance for innate resistance. In contrast, low-dose aerosol infection performed in parallel in mice deficient in iNOS or TNFRp55 (TNFR of 55 kDa), both known to be critical components of innate immunity, resulted in significantly increased pulmonary bacterial loads, in agreement with previously published data (Refs. 15 and 24 ; data not shown). All iNOS-/- and TNFRp55-/- mice died around day 50, whereas control mice and all mice deficient in PRRs were still alive even at 14 wk postinfection. In summary, the presence of CD14, TLR4, or TLR2 is dispensable for mounting adequate innate resistance to aerogenic infection with M. tuberculosis.



View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 1. M. tuberculosis CFU counts in the lungs of aerosol-infected mice deficient in CD14, TLR4, or TLR2 function. Control (•) and deficient mice ({circ}) were aerogenically infected with 100 CFU M. tuberculosis. CFU counts were determined at indicated time points. Lungs were taken from BALB/c and CD14-/- (a), C3H/HeN and TLR4-defective C3H/HeJ (b), and C57BL/6 and TLR2-/- (c) mice. Data represent means ± SD of four mice. One experiment representative of three performed is shown.

 
Analysis of immune responses in the lungs of M. tuberculosis-infected mice defective in CD14, TLR2, or TLR4

Because containment of bacterial replication is only one facet of an effective immune response, we analyzed whether other parameters indicative of inflammatory and protective processes might be altered in defective mice. IL-12p40, TNF, and IFN-{gamma} were produced at comparably high levels independently of CD14-, TLR2-, or TLR4-mediated signaling in the lungs of M. tuberculosis-infected mice (Table IGo). There were significant differences in the absolute amount of cytokines detected in lung homogenates between the three groups of mice examined, likely reflecting the difference in their genetic backgrounds.


View this table:
[in this window]
[in a new window]
  		Table I. Cytokine production in lung homogenates from CD14-, TLR2-, and TLR4-defective mice after infection with M. tuberculosis

 
It was reported that M. tuberculosis-derived TLR2 agonists inhibit Ag processing and MHC class II expression in macrophages. However, flow cytometric analysis of bronchioalveolar macrophages at day 21 postinfection showed no significant difference in the expression levels of MHC class II in M. tuberculosis-infected TLR2-deficient vs congenic control mice (data not shown). This was paralleled by comparably increased numbers of CD4+, CD8+, and activated CD4+ cells in mediastinal lymph nodes (data not shown) as well as efficient epithelioid granuloma formation in all groups of mice (Fig. 2Go and data not shown). In addition, iNOS expression, a marker of macrophage activation, was similar in granulomatous lesions in lungs from mice defective in CD14, TLR2, or TLR4 and congenic control mice (Fig. 2Go and data not shown).



View larger version (90K):
[in this window]
[in a new window]
  		FIGURE 2. Granuloma formation in the lungs of M. tuberculosis-infected TLR2-/- mice. Sections (2–3 µm) were prepared from formalin-fixed lungs taken from TLR2-/- and C57BL/6 mice 49 days after aerosol infection with 100 CFU M. tuberculosis. Immunohistological staining was performed with a polyclonal rabbit anti-mouse iNOS antiserum. Shown are representative results of four mice per group obtained in three independent experiments. Arrows indicate lymphocyte aggregates; brown staining shows iNOS-positive epithelioid macrophages. Bar, 0.5 mm.

 
Recently, signaling via TLRs was implicated in generating adaptive immune responses (25). Our data obtained in low-dose aerosol infection with M. tuberculosis argue that development of adaptive immunity, as revealed by the generation of effector T cells and the prolonged containment of bacterial loads in compact granulomas, can also effectively proceed in a CD14-, TLR2-, or TLR4-independent fashion. A limitation of our study is that the observation period does not cover the entire life span of infected mice. Therefore, mechanisms active predominantly in controlling chronically persistent infection, e.g., release of perforin (26), may still be regulated by TLRs. Also, recent findings point to combinatorial actions of TLRs (27). It is therefore possible that the lack of more than one TLR would impair innate immunity to M. tuberculosis infection. Experiments in TLR2/TLR4 double-deficient mice and in mice lacking the TLR adaptor molecule MyD88 (28) are required to resolve this issue.

M. tuberculosis infection of bone-marrow derived macrophages from mice deficient in CD14, TLR2, or TLR4

The results from our aerosol infection in mutant mice is in striking contrast to the hypothesized critical role for PRRs in innate immune responses. However, current thinking is primarily based on results obtained from in vitro stimulation experiments performed on cell lines transfected with, e.g., CD14, TLR2, or TLR4 (11, 29). To date, few data are available from primary macrophages addressing the roles of PRRs for initiating cytokine secretion in response to M. tuberculosis.

We found TNF and IL-12p40 production after infection of murine primary macrophages with live M. tuberculosis to be independent of CD14 (Fig. 3Goa, 3 day). In contrast, in TLR2-/- macrophages, TNF and IL-12p40 production were drastically reduced after stimulation with M. tuberculosis (Fig. 3Go, b and e). Although TNF production was not significantly decreased, IL-12p40 levels were ~65% lower in TLR4-defective C3H/HeJ macrophages when compared with simultaneously infected C3H/HeN macrophages (Fig. 3Go, c and f). Taken together, our in vitro infection experiments with primary macrophages corroborate earlier reports in transfected cells (11, 29) and show that engagement of TLR2 and TLR4 on macrophages indeed contributes to proinflammatory cytokine secretion in response to M. tuberculosis, whereas CD14 is not involved.



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 3. M. tuberculosis-induced TNF and IL-12p40 secretion in bone marrow-derived macrophages from CD14- or TLR2-deficient or TLR4-defective mice. Bone marrow-derived macrophages from CD14-/- (a and d), TLR2-/- (b and e), and TLR4-defective C3H/HeJ (c and f) as well as control mice were incubated with indicated multiplicities of infection (MOI) of viable M. tuberculosis. Supernatants were harvested 24 or 96 h after infection and measured for TNF and IL-12p40 concentrations, respectively. Data from one representative experiment of three are shown. Each point indicates the means + SD (error bars) of triplicate values. *, p < 0.05; **, p < 0.005; ***, p < 0.005; n.s., not significant.

 
High-dose aerosol infection with M. tuberculosis in TLR4-defective and TLR2-deficient mice

If TLR2- and TLR4-mediated signals significantly contribute to proinflammatory cytokine secretion in vitro, how is it possible that defective signaling in either of these molecules does not result in a discernible lack of resistance during aerosol infection in vivo? In gene-deficient mice, a distinct phenotype may often only become apparent if the missing molecule plays a nonredundant role. Additional insight may be gained from examining an experimental situation in which compensatory processes are minimized and in which even molecules that are not essential during a natural exposure need to be recruited to control the insult. In support of this reasoning, increased susceptibility of TLR2-/- mice to i.v. Staphylococcus aureus infection was only apparent when a very high inoculum dose of 1 x 107 CFU, representing an LD50 for wildtype mice, was used (30).

To mimick a similar situation in the M. tuberculosis model, mice were infected with an inoculum of 2000 CFU by aerosol. TLR4-defective C3H/HeJ mice still proved to be as resistant to high-dose infection with M. tuberculosis as C3H/HeN mice (Fig. 4Goa), confirming previous results from a high-dose i.v. infection model (31). Both groups of mice produced similar amounts of IL-12p40 following high-dose infection, providing a likely explanation for the similar outcome in these mice (Fig. 4Goa). In striking contrast, TLR2-/- mice were significantly more susceptible to high-dose aerosol M. tuberculosis infection than control mice (Fig. 4Gob). This enhanced susceptibility could be attributed to a significantly decreased proinflammatory response of TLR2-/- mice as evidenced by reduced serum levels of IL-12p40 10 days postinfection (Fig. 4Gob). These data clearly implicate TLR2, but not TLR4, in initiating antibacterial resistance in a borderline situation presented by a high inoculum.



View larger version (35K):
[in this window]
[in a new window]
  		FIGURE 4. High-dose aerosol infection of TLR4-defective or TLR2-deficient mice with M. tuberculosis. Control (•) and deficient mice ({circ}) were aerogenically infected with 2000 CFU M. tuberculosis. C3H/HeN and C3H/HeJ mice (a; 6 mice per group) or TLR2-/- and C57BL/6 mice (b; 10 mice per group) were monitored for survival. Moribund mice were sacrificed. Survival rates of C57BL/6 and TLR2-/- mice were significantly different (p < 0.05). After 10 days, a separate identically infected group of mice was sacrificed to determine IL-12p40 production in serum. ELISA data represent means ± SD of 4 mice per group. Differences in IL-12p40 production between C57BL/6 and TLR2-/- mice were statistically significant (*, p < 0.05; n.s., not significant).

 
Collectively, our findings may be interpreted as follows: during natural, i.e., aerogenic and low-dose infection, M. tuberculosis triggers little, if any, response via CD14, TLR4, or TLR2. This may reflect the preferred mode of "surreptitious entry" for this highly pathogenic organism, causing as little inflammation as possible to establish infection in the lung and regional lymph nodes. Our results thus support the notion that a single deficiency in PRRs capable of detecting mycobacteria or mycobacterial components (such as CD14, TLR4, or TLR2) does not impair innate resistance to natural M. tuberculosis infection.


   Acknowledgments
 
We thank Johanna Suwinski for expert technical assistance with in vivo infections and Sven Mohr for taking care of the mice.


   Footnotes
 
1 This work was supported in part by a research grant from the Deutsche Forschungsgemeinschaft (SFB 415, C7). Back

2 N.R. and C.H. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Stefan Ehlers, Division of Molecular Infection Biology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. E-mail address: sehlers{at}fz-borstel.de Back

4 Abbreviations used in this paper: PRR, pattern recognition receptor, TLR, Toll-like receptor; iNOS, inducible NO synthase. Back

Received for publication July 8, 2002. Accepted for publication August 9, 2002.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. World Health Organization. 2002. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. Geneva, Switzerland, WHO/CDS/TB/2002.295.
  2. North, R. J.. 1995. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis. 172:1550.[Medline]
  3. McMurray, D. N., F. M. Collins, Jr A. M. Dannenberg, D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol. 215:157.[Medline]
  4. Saunders, B. M., A. M. Cooper. 2000. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78:334.[Medline]
  5. Flynn, J. L., J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12:432.[Medline]
  6. Kaufmann, S. H.. 2001. How can immunology contribute to the control of tuberculosis?. Nature Rev. Immunol. 1:20.[Medline]
  7. Trinchieri, G.. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14:335.[Medline]
  8. Akira, S., K. Takeda, T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.[Medline]
  9. Aderem, A., R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.[Medline]
  10. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1{beta} and tumor necrosis factor-{alpha} by Mycobacterium tuberculosis components. J. Clin. Invest 91:2076.
  11. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920.[Abstract/Free Full Text]
  12. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, et al 2001. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544.[Abstract/Free Full Text]
  13. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732.[Abstract/Free Full Text]
  14. Holscher, C., R. A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957.[Abstract/Free Full Text]
  15. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor-{alpha} is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:561.[Medline]
  16. van Crevel, R., T. H. Ottenhoff, J. W. Der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15:294.[Abstract/Free Full Text]
  17. Stenger, S., R. L. Modlin. 2002. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14:452.[Medline]
  18. Heldwein, K. A., M. J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4:937.[Medline]
  19. Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, G. Saint, I. D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346.[Medline]
  20. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 4:407.[Medline]
  21. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  22. Reiling, N., K. Klug, U. Krallmann-Wenzel, R. Laves, S. M. Goyert, M. E. Taylor, T. K. Lindhorst, S. Ehlers. 2001. Complex encounters at the macrophage-mycobacterium interface: studies on the role of the mannose receptor and CD14 in experimental infection models with Mycobacterium avium. Immunobiology 204:558.[Medline]
  23. Cooper, A. M., J. E. Pearl, J. V. Brooks, S. Ehlers, I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68:6879.[Abstract/Free Full Text]
  24. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243.[Abstract/Free Full Text]
  25. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947.[Medline]
  26. Sousa, A. O., R. J. Mazzaccaro, R. G. Russell, F. K. Lee, O. C. Turner, S. Hong, L. Van Kaer, B. R. Bloom. 2000. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97:4204.[Abstract/Free Full Text]
  27. Hajjar, A. M., D. S. O’Mahony, A. Ozinsky, D. M. Underhill, A. Aderem, S. J. Klebanoff, C. B. Wilson. 2001. Cutting edge: functional interactions between Toll-like receptor (TLR)2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166:15.[Abstract/Free Full Text]
  28. Takeuchi, O., K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12:113.[Abstract/Free Full Text]
  29. Means, T. K., B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, M. J. Fenton. 2001. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:4074.[Abstract/Free Full Text]
  30. Takeuchi, O., K. Hoshino, S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392.[Abstract/Free Full Text]
  31. Chackerian, A. A., T. V. Perera, S. M. Behar. 2001. {gamma} interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69:2666.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 JEMHome page
A. Tanne, B. Ma, F. Boudou, L. Tailleux, H. Botella, E. Badell, F. Levillain, M. E. Taylor, K. Drickamer, J. Nigou, et al.
A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis
J. Exp. Med., September 28, 2009; 206(10): 2205 - 2220.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. Almeida, P. M. Lago, N. Boechat, R. C. Huard, L. C. O. Lazzarini, A. R. Santos, M. Nociari, H. Zhu, B. M. Perez-Sweeney, H. Bang, et al.
Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity
J. Immunol., July 1, 2009; 183(1): 718 - 731.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Peduto, S. Dulauroy, M. Lochner, G. F. Spath, M. A. Morales, A. Cumano, and G. Eberl
Inflammation Recapitulates the Ontogeny of Lymphoid Stromal Cells
J. Immunol., May 1, 2009; 182(9): 5789 - 5799.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
A. YOSHIDA, H. INAGAWA, C. KOHCHI, T. NISHIZAWA, and G.-I. SOMA
The Role of Toll-like Receptor 2 in Survival Strategies of Mycobacterium tuberculosis in Macrophage Phagosomes
Anticancer Res, March 1, 2009; 29(3): 907 - 910.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Divangahi, S. Mostowy, F. Coulombe, R. Kozak, L. Guillot, F. Veyrier, K. S. Kobayashi, R. A. Flavell, P. Gros, and M. A. Behr
NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity
J. Immunol., November 15, 2008; 181(10): 7157 - 7165.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
S. K. Rampini, P. Selchow, C. Keller, S. Ehlers, E. C. Bottger, and P. Sander
LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest
Microbiology, October 1, 2008; 154(10): 2991 - 3001.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Schaefer, N. Reiling, C. Fessler, J. Stephani, I. Taniuchi, F. Hatam, A. O. Yildirim, H. Fehrenbach, K. Walter, J. Ruland, et al.
Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection
J. Immunol., May 15, 2008; 180(10): 6836 - 6845.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Gandotra, S. Jang, P. J. Murray, P. Salgame, and S. Ehrt
Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis
Infect. Immun., November 1, 2007; 75(11): 5127 - 5134.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
T. V. Guidry, R. L. Hunter Jr, and J. K. Actor
Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes
Microbiology, October 1, 2007; 153(10): 3360 - 3369.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Z. Kincaid, A. J. Wolf, L. Desvignes, S. Mahapatra, D. C. Crick, P. J. Brennan, M. S. Pavelka Jr., and J. D. Ernst
Codominance of TLR2-Dependent and TLR2-Independent Modulation of MHC Class II in Mycobacterium tuberculosis Infection In Vivo
J. Immunol., September 1, 2007; 179(5): 3187 - 3195.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Fremond, D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. F. J. Quesniaux
IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection
J. Immunol., July 15, 2007; 179(2): 1178 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Pompei, S. Jang, B. Zamlynny, S. Ravikumar, A. McBride, S. P. Hickman, and P. Salgame
Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs
J. Immunol., April 15, 2007; 178(8): 5192 - 5199.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. KuoLee, X. Zhao, J. Austin, G. Harris, J. W. Conlan, and W. Chen
Mouse Model of Oral Infection with Virulent Type A Francisella tularensis
Infect. Immun., April 1, 2007; 75(4): 1651 - 1660.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Basu, S. K. Pathak, A. Banerjee, S. Pathak, A. Bhattacharyya, Z. Yang, S. Talarico, M. Kundu, and J. Basu
Execution of Macrophage Apoptosis by PE_PGRS33 of Mycobacterium tuberculosis Is Mediated by Toll-like Receptor 2-dependent Release of Tumor Necrosis Factor-{alpha}
J. Biol. Chem., January 12, 2007; 282(2): 1039 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Kurtz, K. P. McKinnon, M. S. Runge, J. P.-Y. Ting, and M. Braunstein
The SecA2 Secretion Factor of Mycobacterium tuberculosis Promotes Growth in Macrophages and Inhibits the Host Immune Response
Infect. Immun., December 1, 2006; 74(12): 6855 - 6864.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Yadav and J. S. Schorey
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria
Blood, November 1, 2006; 108(9): 3168 - 3175.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Blumenthal, S. Ehlers, J. Lauber, J. Buer, C. Lange, T. Goldmann, H. Heine, E. Brandt, and N. Reiling
The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation
Blood, August 1, 2006; 108(3): 965 - 973.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Keller, R. Hoffmann, R. Lang, S. Brandau, C. Hermann, and S. Ehlers
Genetically Determined Susceptibility to Tuberculosis in Mice Causally Involves Accelerated and Enhanced Recruitment of Granulocytes
Infect. Immun., July 1, 2006; 74(7): 4295 - 4309.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. D. Pecora, A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding
Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function
J. Immunol., July 1, 2006; 177(1): 422 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Katz, P. Zhang, M. Martin, S. N. Vogel, and S. M. Michalek
Toll-Like Receptor 2 Is Required for Inflammatory Responses to Francisella tularensis LVS.
Infect. Immun., May 1, 2006; 74(5): 2809 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. M. Tufariello, K. Mi, J. Xu, Y. C. Manabe, A. K. Kesavan, J. Drumm, K. Tanaka, W. R. Jacobs Jr., and J. Chan
Deletion of the Mycobacterium tuberculosis Resuscitation-Promoting Factor Rv1009 Gene Results in Delayed Reactivation from Chronic Tuberculosis.
Infect. Immun., May 1, 2006; 74(5): 2985 - 2995.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Fricke, D. Mitchell, J. Mittelstadt, N. Lehan, H. Heine, T. Goldmann, A. Bohle, and S. Brandau
Mycobacteria Induce IFN-{gamma} Production in Human Dendritic Cells via Triggering of TLR2
J. Immunol., May 1, 2006; 176(9): 5173 - 5182.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Buwitt-Beckmann, H. Heine, K.-H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A. J. Ulmer
TLR1- and TLR6-independent Recognition of Bacterial Lipopeptides
J. Biol. Chem., April 7, 2006; 281(14): 9049 - 9057.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
Y.-T.A. Teng
Protective and Destructive Immunity in the Periodontium: Part 1--Innate and Humoral Immunity and the Periodontium
Journal of Dental Research, March 1, 2006; 85(3): 198 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-S. Chang, J. F. Huggett, K. Dheda, L. U. Kim, A. Zumla, and G. A. W. Rook
Myobacterium tuberculosis Induces Selective Up-Regulation of TLRs in the Mononuclear Leukocytes of Patients with Active Pulmonary Tuberculosis.
J. Immunol., March 1, 2006; 176(5): 3010 - 3018.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
J. Exp. Med., December 19, 2005; 202(12): 1715 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. B. Su, P. B. Silver, R. S. Grajewski, R. K. Agarwal, J. Tang, C.-C. Chan, and R. R. Caspi
Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity
J. Immunol., November 15, 2005; 175(10): 6303 - 6310.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Kielian, A. Haney, P. M. Mayes, S. Garg, and N. Esen
Toll-Like Receptor 2 Modulates the Proinflammatory Milieu in Staphylococcus aureus-Induced Brain Abscess
Infect. Immun., November 1, 2005; 73(11): 7428 - 7435.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. G. Netea, J. W. M. Van der Meer, R. P. Sutmuller, G. J. Adema, and B.-J. Kullberg
From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias
Antimicrob. Agents Chemother., October 1, 2005; 49(10): 3991 - 3996.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Shi, A. Blumenthal, C. M. Hickey, S. Gandotra, D. Levy, and S. Ehrt
Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-{alpha}{beta} Receptor and STAT1
J. Immunol., September 1, 2005; 175(5): 3318 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Matsumoto, M. Matsumoto, K. Umemori, Y. Ozeki, M. Furugen, T. Tatsuo, Y. Hirayama, S. Yamamoto, T. Yamada, and K. Kobayashi
DNA Augments Antigenicity of Mycobacterial DNA-Binding Protein 1 and Confers Protection against Mycobacterium tuberculosis Infection in Mice
J. Immunol., July 1, 2005; 175(1): 441 - 449.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Bulut, K. S. Michelsen, L. Hayrapetian, Y. Naiki, R. Spallek, M. Singh, and M. Arditi
Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals
J. Biol. Chem., June 3, 2005; 280(22): 20961 - 20967.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Blumenthal, J. Lauber, R. Hoffmann, M. Ernst, C. Keller, J. Buer, S. Ehlers, and N. Reiling
Common and Unique Gene Expression Signatures of Human Macrophages in Response to Four Strains of Mycobacterium avium That Differ in Their Growth and Persistence Characteristics
Infect. Immun., June 1, 2005; 73(6): 3330 - 3341.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y. Maeda, T. Mukai, J. Spencer, and M. Makino
Identification of an Immunomodulating Agent from Mycobacterium leprae
Infect. Immun., May 1, 2005; 73(5): 2744 - 2750.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. E. Geisel, K. Sakamoto, D. G. Russell, and E. R. Rhoades
In Vivo Activity of Released Cell Wall Lipids of Mycobacterium bovis Bacillus Calmette-Guerin Is Due Principally to Trehalose Mycolates
J. Immunol., April 15, 2005; 174(8): 5007 - 5015.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Holscher, A. Holscher, D. Ruckerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers
The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis
J. Immunol., March 15, 2005; 174(6): 3534 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. W. Wieland, S. Knapp, S. Florquin, A. F. de Vos, K. Takeda, S. Akira, D. T. Golenbock, A. Verbon, and T. van der Poll
Non-Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1367 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. Nicolle, C. Fremond, X. Pichon, A. Bouchot, I. Maillet, B. Ryffel, and V. J. F. Quesniaux
Long-Term Control of Mycobacterium bovis BCG Infection in the Absence of Toll-Like Receptors (TLRs): Investigation of TLR2-, TLR6-, or TLR2-TLR4-Deficient Mice
Infect. Immun., December 1, 2004; 72(12): 6994 - 7004.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. J. Frodsham and A. V.S. Hill
Genetics of infectious diseases
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R187 - R194.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. E. Yauch, M. K. Mansour, S. Shoham, J. B. Rottman, and S. M. Levitz
Involvement of CD14, Toll-Like Receptors 2 and 4, and MyD88 in the Host Response to the Fungal Pathogen Cryptococcus neoformans In Vivo
Infect. Immun., September 1, 2004; 72(9): 5373 - 5382.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Jang, S. Uematsu, S. Akira, and P. Salgame
IL-6 and IL-10 Induction from Dendritic Cells in Response to Mycobacterium tuberculosis Is Predominantly Dependent on TLR2-Mediated Recognition
J. Immunol., September 1, 2004; 173(5): 3392 - 3397.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. W. Brattig, C. Bazzocchi, C. J. Kirschning, N. Reiling, D. W. Buttner, F. Ceciliani, F. Geisinger, H. Hochrein, M. Ernst, H. Wagner, et al.
The Major Surface Protein of Wolbachia Endosymbionts in Filarial Nematodes Elicits Immune Responses through TLR2 and TLR4
J. Immunol., July 1, 2004; 173(1): 437 - 445.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bafica, C. A. Scanga, M. Schito, D. Chaussabel, and A. Sher
Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors
J. Immunol., June 15, 2004; 172(12): 7229 - 7234.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Vazquez-Torres, B. A. Vallance, M. A. Bergman, B. B. Finlay, B. T. Cookson, J. Jones-Carson, and F. C. Fang
Toll-Like Receptor 4 Dependence of Innate and Adaptive Immunity to Salmonella: Importance of the Kupffer Cell Network
J. Immunol., May 15, 2004; 172(10): 6202 - 6208.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. G. Netea, C. van der Graaf, J. W. M. Van der Meer, and B. J. Kullberg
Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system
J. Leukoc. Biol., May 1, 2004; 75(5): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Basu and M. J. Fenton
Toll-like receptors: function and roles in lung disease
Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L887 - L892.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. A. Scanga, A. Bafica, C. G. Feng, A. W. Cheever, S. Hieny, and A. Sher
MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression
Infect. Immun., April 1, 2004; 72(4): 2400 - 2404.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. C. Derrick, C. Repique, P. Snoy, A. L. Yang, and S. Morris
Immunization with a DNA Vaccine Cocktail Protects Mice Lacking CD4 Cells against an Aerogenic Infection with Mycobacterium tuberculosis
Infect. Immun., March 1, 2004; 72(3): 1685 - 1692.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. Branger, J. C. Leemans, S. Florquin, S. Weijer, P. Speelman, and T. van der Poll
Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice
Int. Immunol., March 1, 2004; 16(3): 509 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.C. Ogus, B. Yoldas, T. Ozdemir, A. Uguz, S. Olcen, I. Keser, M. Coskun, A. Cilli, and O. Yegin
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease
Eur. Respir. J., February 1, 2004; 23(2): 219 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. B. Drennan, D. Nicolle, V. J. F. Quesniaux, M. Jacobs, N. Allie, J. Mpagi, C. Fremond, H. Wagner, C. Kirschning, and B. Ryffel
Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection
Am. J. Pathol., January 1, 2004; 164(1): 49 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. G. Feng, C. A. Scanga, C. M. Collazo-Custodio, A. W. Cheever, S. Hieny, P. Caspar, and A. Sher
Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals
J. Immunol., November 1, 2003; 171(9): 4758 - 4764.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Peters, R. E. Unger, J. Brunner, and C.J. Kirkpatrick
Molecular basis of endothelial dysfunction in sepsis
Cardiovasc Res, October 15, 2003; 60(1): 49 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. L. Coleman and J. L. Benach
The Urokinase Receptor Can Be Induced by Borrelia burgdorferi through Receptors of the Innate Immune System
Infect. Immun., October 1, 2003; 71(10): 5556 - 5564.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. A. Heldwein, M. D. Liang, T. K. Andresen, K. E. Thomas, A. M. Marty, N. Cuesta, S. N. Vogel, and M. J. Fenton
TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG
J. Leukoc. Biol., August 1, 2003; 74(2): 277 - 286.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bafica, C. A. Scanga, M. L. Schito, S. Hieny, and A. Sher
Cutting Edge: In Vivo Induction of Integrated HIV-1 Expression by Mycobacteria Is Critically Dependent on Toll-Like Receptor 2
J. Immunol., August 1, 2003; 171(3): 1123 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Martin, R. E. Schifferle, N. Cuesta, S. N. Vogel, J. Katz, and S. M. Michalek
Role of the Phosphatidylinositol 3 Kinase-Akt Pathway in the Regulation of IL-10 and IL-12 by Porphyromonas gingivalis Lipopolysaccharide
J. Immunol., July 15, 2003; 171(2): 717 - 725.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. B. Kamath, J. Alt, H. Debbabi, and S. M. Behar
Toll-Like Receptor 4-Defective C3H/HeJ Mice Are Not More Susceptible than Other C3H Substrains to Infection with Mycobacterium tuberculosis
Infect. Immun., July 1, 2003; 71(7): 4112 - 4118.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiling, N.
Right arrow Articles by Ehlers, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiling, N.
Right arrow Articles by Ehlers, S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS